RecruitingNot Applicable

Registry of the German CLL Study Group

Germany8,000 participantsStarted 2013-08

Plain-language summary

Long term follow-up of patients with chronic lymphocytic leukemia (CLL), B-prolymphocytic leukemia (B-PLL), T-cell prolymphocytic leukemia (T-PLL), Small lymphocytic lymphoma (SLL), T/Natural Killer large granular lymphocyte leukemia (T or NK-LGL), Hairy cell leukemia (HCL) and Richter's transformation

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Confirmed diagnosis of CLL, B-PLL, T-PLL, SLL, T or NK-LGL, HCL or Richter's transformation
✓. 18 years of age or older
✓. Signed, written informed consent
✓. Presence of one or more of the following disease situations:

Exclusion criteria

✕. Patients without confirmed diagnosis of CLL, B-PLL, T-PLL, SLL, T or NK- LGL, HCL or Richter's transformation
✕. Cerebral dysfunction, legal incapacity

What they're measuring

Overall Survival

Timeframe: from date of registry entry until date of death, up to 12 years

Trial details

NCT IDNCT02863692

SponsorGerman CLL Study Group

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-12

Contact for this trial

Anna-Maria Fink, MD

+4922147888220 cllstudie@uk-koeln.de

View on ClinicalTrials.gov More CLL trials